Literature DB >> 6822298

Immobilized adriamycin: a tool for separating cell surface from intracellular mechanisms.

T R Tritton, G Yee, L B Wingard.   

Abstract

Pharmacologic agents may exert their biological activity at the level of the cell membrane. Of particular interest is the anticancer agent adriamycin. This drug has previously been considered to act by intercalation with nuclear DNA, but recent evidence suggests the possibility that the cell surface membrane may represent an alternative target. To test this hypothesis, adriamycin was attached to insoluble supports, and conditions suggesting that the drug was actively cytotoxic without entering cells were demonstrated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822298

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  7 in total

Review 1.  Prodrugs for the improvement of drug absorption via different routes of administration.

Authors:  L P Balant; E Doelker; P Buri
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

2.  Cardiotoxicity and antitumor activity of a copper(II)-doxorubicin chelate.

Authors:  E Monti; L Paracchini; F Piccinini; V Malatesta; F Morazzoni; R Supino
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Transformation with SV40 virus prevents retinoic acid inhibition of plasma membrane NADH diferric transferrin reductase in rat liver cells.

Authors:  I L Sun; W Toole-Simms; F L Crane; D J Morré; H Löw; J Y Chou
Journal:  J Bioenerg Biomembr       Date:  1988-06       Impact factor: 2.945

4.  Fluorescence depolarization measurements on oriented membranes.

Authors:  M Adler; T R Tritton
Journal:  Biophys J       Date:  1988-06       Impact factor: 4.033

5.  Inhibition of plasma membrane NADH dehydrogenase by adriamycin and related anthracycline antibiotics.

Authors:  I L Sun; F L Crane; H Löw; C Grebing
Journal:  J Bioenerg Biomembr       Date:  1984-06       Impact factor: 2.945

6.  Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells.

Authors:  A Colin de Verdière; C Dubernet; F Nemati; M F Poupon; F Puisieux; P Couvreur
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Anthracycline-induced inhibition of membrane permeability functions dependent on metabolic energy.

Authors:  A C Croce; E Prosperi; R Supino; G Bottiroli
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.